Oncology Treatment Tourism Global Market Report 2026

The oncology treatment tourism market size has grown rapidly in recent years. It will grow from $6.99 billion in 2025 to $7.71 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing global cancer prevalence, high cost of oncology treatment in developed countries, limited access to advanced therapies in home countries, growth of medical tourism infrastructure, rising awareness of international treatment options.

The oncology treatment tourism market size is expected to see rapid growth in the next few years. It will grow to $11.54 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing adoption of personalized oncology therapies, expansion of international insurance coverage for cross-border care, growing investment in specialized cancer centers, rising demand for shorter treatment waiting times, increasing collaborations between global healthcare providers. Major trends in the forecast period include rising cross-border access to advanced cancer therapies, growing demand for cost-effective oncology treatments, expansion of international cancer centers of excellence, increasing partnerships between hospitals and medical tourism agencies, rising preference for integrated treatment and hospitality packages.

The increasing prevalence of cancer is expected to propel the growth of the oncology treatment tourism market going forward. Cancer comprises diseases characterized by uncontrolled growth and spread of abnormal cells that can invade surrounding tissues and metastasize to distant organs. The rise in cancer prevalence is attributed to aging populations, as older individuals have a higher risk of accumulating genetic mutations that may lead to cancer. Oncology treatment tourism supports patients by providing access to advanced therapies, specialized oncologists, and innovative treatment protocols that may not be readily available in their home countries. It helps reduce treatment costs and waiting times while offering comprehensive care packages, improving accessibility, continuity of care, and overall outcomes. For example, in February 2024, the World Health Organization, a Switzerland-based international organization, projected over 35 million new cancer cases in 2050, a 77% increase from the 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the oncology treatment tourism market.

Leading companies operating in the oncology treatment tourism market are focusing on developing advanced solutions, such as advanced oncology therapeutics, to enhance precision treatment and clinical outcomes for late-stage cancer patients. Advanced oncology therapeutics refers to a class of innovative medical treatments designed to target cancer at the molecular, cellular, or genetic level. For example, in September 2025, Booking Health, a Germany-based medical travel facilitator, expanded its services to improve international access to advanced stage 4 cancer treatments, including immunotherapy, CAR T-cell therapy, and theranostics. The platform offers comprehensive coordination for patients, covering second opinions, personalized treatment plans, travel logistics, and follow-up care. By connecting patients with top-certified German hospitals such as LMU Klinikum, these services enable access to cutting-edge oncology options like HIPEC, PIPAC, and radioembolization (Y-90), which are designed to improve survival outcomes, enhance treatment precision, and support patient-centered cancer care.

In January 2024, PureHealth, a United Arab Emirates-based integrated healthcare provider, acquired Circle Health Group for approximately $1.2 billion. Through this acquisition, PureHealth aims to expand its international hospital network and enhance access to advanced oncology and specialty care services for cross-border patients seeking treatment in the UK. Circle Health Group is a UK-based private hospital company providing oncology treatment services to international patients.

Major companies operating in the oncology treatment tourism market are Mayo Clinic, Memorial Sloan Kettering Cancer Center, Cleveland Clinic, Johns Hopkins Medicine, Apollo Hospitals, Charité-Universitätsmedizin Berlin, Sheba Medical Center, Dana-Farber Cancer Institute, The Royal Marsden Hospital, Seoul National University Hospital, Clínica Universidad de Navarra, Karolinska University Hospital, Institut Curie, Istituto Nazionale dei Tumori, Asan Medical Center, Netherlands Cancer Institute, The Christie NHS Foundation Trust, Cancer Institute Hospital of JFCR, HCG Cancer Centre, Princess Margaret Cancer Centre, MD Anderson Cancer Center.

North America was the largest region in the oncology treatment tourism market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology treatment tourism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the oncology treatment tourism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oncology treatment tourism market includes revenues earned by entities through medical consultation, treatment planning, hospital services, accommodation arrangements, travel coordination, post-treatment follow-ups, and personalized patient care. The market value includes the value of related goods and services sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology treatment tourism refers to patients traveling internationally to access specialized cancer treatments, including chemotherapy, radiotherapy, surgery, immunotherapy, and personalized care. This sector combines advanced medical services with travel and hospitality support, enabling patients to obtain therapies that may be unavailable or unaffordable in their home countries while offering cost-effective and timely care.

The primary treatment types of oncology treatment tourism include chemotherapy, radiation therapy, immunotherapy, targeted therapy, surgical oncology, and other modalities. Chemotherapy is a method that uses drugs to destroy or slow the growth of cancer cells in the body. Patient profiles include adults, pediatrics, and geriatrics, with booking facilitated through direct booking, online platforms, and medical tourism agencies. Services are provided by hospitals, specialty clinics, cancer centers, and other providers.

Tariffs on imported medical equipment, radiotherapy machines, surgical robotics, and oncology pharmaceuticals are influencing the oncology treatment tourism market by increasing operational costs for hospitals and specialty cancer centers. Regions heavily dependent on imported advanced oncology technologies, particularly in Asia-Pacific and the Middle East, are most affected. Treatment segments such as radiation therapy and immunotherapy may experience pricing pressures due to higher equipment and drug costs. However, tariffs can also encourage local manufacturing of oncology equipment and pharmaceuticals, strengthening domestic healthcare infrastructure and enhancing long-term competitiveness in the medical tourism sector.

The oncology treatment tourism market research report is one of a series of new reports that provides oncology treatment tourism market statistics, including oncology treatment tourism industry global market size, regional shares, competitors with a oncology treatment tourism market share, detailed oncology treatment tourism market segments, market trends and opportunities, and any further data you may need to thrive in the oncology treatment tourism industry. This oncology treatment tourism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.